Related Experiment Video
Updated: Dec 18, 2025

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Long Term Clinical Outcomes in Patients with Moderate Aortic Stenosis
Han Joon Bae1, Jongmin Hwang1, Seongwook Han1
1Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, Republic of Korea.
Insights
Symptomatic patients with moderate aortic stenosis (AS) face higher risks than expected. Early intervention is recommended for those with diabetes mellitus (DM) and mitral regurgitation (MR).
Area of Science:
- Cardiology
- Clinical Medicine
- Medical Research
Background:
- Current guidelines suggest watchful waiting for moderate aortic stenosis (AS).
- Clinical outcomes for moderate AS with comorbidities are not well-studied.
- This study investigates factors influencing moderate AS outcomes over five years.
Purpose of the Study:
- To explore factors contributing to adverse outcomes in moderate AS patients.
- To evaluate the 5-year composite endpoint of cardiovascular death, heart failure aggravation, or aortic valve replacement.
- To identify predictors of poor outcomes in this patient cohort.
Main Methods:
- Retrospective review of 148 moderate AS patients (2008-2012).
- Gathering of echocardiographic data and 5-year clinical outcomes.
- Multivariate analysis to identify independent predictors of adverse events.
Main Results:
- 79 out of 148 patients experienced adverse outcomes over a mean follow-up of 5.6 years.
- Diabetes mellitus (DM), moderate-to-severe mitral regurgitation (MR), and NYHA class III-IV dyspnea were independently associated with adverse outcomes.
- Worse symptoms, higher DM and MR rates, and smaller aortic valve areas were observed in the adverse event group.
Conclusions:
- Symptomatic moderate AS patients have a higher event rate than anticipated.
- Early intervention should be considered for moderate AS patients with concurrent MR and DM.
- Identifying high-risk patients with moderate AS is crucial for timely management decisions.
Background:
While the surgical correction of moderate aortic stenosis (AS) can be deferred with a watchful waiting according to the present guideline, the clinical outcomes for moderate AS with comorbidity have not extensively been studied. We aimed to explore the factors that would contribute to the outcomes of moderate AS with at least five years of follow-up duration.
Methods:
Medical records review identified patients with moderate aortic valve (AV) stenosis from January 2008 and December 2012. Echocardiographic data were gathered, and the final 5-year clinical outcomes, defined as the composite of cardiovascular (CV) death, admission for heart failure (HF) aggravation, and AV replacement, were evaluated.
Results:
Among 148 patients (mean age, 69.3 years; mean AV area, 1.24 cm2), 79 had adverse outcomes (16 CV deaths, 32 AV replacements, and 31 HF cases), during a mean follow-up of 5.6 years. The event group showed worse dyspnea of NYHA III-IV and a higher frequency of diabetes mellitus (DM). They had a higher frequency of moderate or moderate-to-severe functional mitral regurgitation (MR) and smaller AV area. In the multivariate analysis, DM (HR 2.29, 95% CI 1.03-5.10), moderate or moderate-to-severe MR (HR 4.84, 95% CI 1.66-10.07), and NYHA III-IV (HR 3.84, 95% CI 1.72-8.56) independently were associated with adverse outcomes.
Conclusions:
The symptomatic patients with moderate AS had higher events than expected, and early intervention should be considered in case of concomitant MR and DM.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis III: Medical Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis IV: Nursing Management
Aortic Regurgitation I: Introduction
